MEP Interest Group

The TRANSFORM MEP Interest Group is an informal group that brings together cross-party Members of the European Parliament (MEPs) who are committed to ensuring that innovative and life-changing therapies can timely reach all patients across Europe.

Why an MEP Interest Group on Transformative Therapies?

The European Parliament can play a key role in helping tackle the issues that prevent or delay access to treatments for patients by raising awareness and rethinking the current policy and legislative framework. MEPs can ensure that transformative therapies are considered as a priority in the European agenda, highlighting the potential that these novel therapies can offer to patients, resulting in better health outcomes as well as societal benefits. 

What are the main activities of the MEP Interest Group on Transformative Therapies?

The TRANSFORM MEP Interest Group hosts meetings to inform, educate and promote dialogue with decision-makers to shape the policy and legislative framework to accommodate these transformative therapies for the benefit of patients.  

Chair

(RE, Czech Republic)

Supporting Members

Claudia Gamon
Claudia Gamon
(RE, Austria)
Billy Kelleher
Billy Kelleher
(RE, Ireland)
Susana Solís Pérez
Susana Solís Pérez
(RE, Spain)
Tomislav Sokol
Tomislav Sokol
(EPP, Croatia)
Sirpa Pietikäinen
Sirpa Pietikäinen
(EPP, Finland)
Aldo Patriciello
Aldo Patriciello
(EPP, Italy)
Nicolás González Casares
Nicolás González Casares
(S&D, Spain)
Cyrus Engerer
Cyrus Engerer
(S&D, Malta)
Manuel Pizarro
Manuel Pizarro
(S&D, Portugal)
Juozas Olekas
Juozas Olekas
(S&D, Lithuania)
Tudor Ciuhodaru
Tudor Ciuhodaru
(S&D, Romania)
Pietro Fiocchi
Pietro Fiocchi
(ECR, Italy)
Emmanouil Fragkos
Emmanouil Fragkos
(ECR, Greece)
Frances Fitzgerald
Frances Fitzgerald
(EPP, Ireland)
Radka Maxová
Radka Maxová
(S&D, Czechia)
Stelios Kympouropoulos
Stelios Kympouropoulos
(EPP, Greece)
Anne Sander
Anne Sander
(EPP, France)
Tilly Metz
Tilly Metz
(Greens/EFA, Luxembourg)
Frédérique Ries
Frédérique Ries
(RE, Belgium)

Events

@TRANSFORM_CGT on Twitter Follow us →

Interesting event @alliancerm today! With the EU Pharma legislation review, the new HTA Regulation and the EHDS, the EU has an opportunity to encourage innovation & ensure that ATMPs are a central part of the EU’s healthcare landscape @Kympouropoulos @susanasolisp #MEPsforATMPs https://t.co/ODkSdMePW9
29 November at 9:07pm
MEP @dieGamon endorses Recommendation 7️⃣ of the TRANSFORM MEP Charter, which calls for improved infrastructure and cross-border healthcare for ATMPs #MEPsforATMPs https://t.co/nDDxEhvqrr
22 November at 11:33am
Hear MEP @susanasolis outline Recommendation 6️⃣ of the TRANSFORM MEP Charter. Considering innovative access pathways for cell and gene therapies could help bring more ATMPs to #patients #MEPsforATMPs https://t.co/R8cs4snLL9
17 November at 10:25am